Paragon Care Limited (ASX:PGC)
0.1900
+0.0100 (5.56%)
Feb 26, 2026, 2:16 PM AEST
Paragon Care Revenue
In the fiscal year ending June 30, 2025, Paragon Care had annual revenue of 3.61B AUD with 21.68% growth. Paragon Care had revenue of 1.76B in the half year ending June 30, 2025.
Revenue
3.61B
Revenue Growth
+21.68%
P/S Ratio
0.08
Revenue / Employee
6.57M
Employees
550
Market Cap
297.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.61B | 644.00M | 21.68% |
| Jun 30, 2024 | 2.97B | 782.54M | 35.78% |
| Jun 30, 2023 | 2.19B | 479.19M | 28.05% |
| Jun 30, 2022 | 1.71B | 91.10M | 5.63% |
| Jun 30, 2021 | 1.62B | 68.44M | 4.42% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.10B |
| Sigma Healthcare | 6.00B |
| Cochlear | 2.34B |
| Australian Clinical Labs | 737.49M |
| Monash IVF Group | 271.92M |
| Pro Medicus | 240.57M |
| Cogstate | 84.06M |
| Aroa Biosurgery | 79.26M |